Naratriptan Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 2 JDMF, 8 EU WC, 3 KDMF, 4 NDC API, 6 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 19 FDA Orange Book, 1 Europe, 3 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 9 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 24 Direct Compression, 21 Controlled & Modified Release, 15 Granulation, 15 Disintegrants & Superdisintegrants, 14 Co-Processed Excipients, 13 Thickeners and Stabilizers, 13 Lubricants & Glidants, 9 Film Formers & Plasticizers, 5 Empty Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Chewable & Orodispersible Aids, 2 Topical, 2 Parenteral, 1 Surfactant & Foaming Agents, 1 Solubilizers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20763 / DOSAGE - TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NARATRIPTAN HYDROCHLORIDE(UNII: 10X8X4P12Z) (NARATRIPTAN - UNII:QX3KXL1ZA2)	NARATRIPTAN	2.5mg \| 1mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC
CROSCARMELLOSE SODIUM(M28OL1HH48)
FD&C BLUE NO. 2(L06K8R7DQK)
FERRIC OXIDE YELLOW(EX438O2MRT)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
INDIGOTINDISULFONATE SODIUM(D3741U8K7L)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIACETIN(XHX3C3X673)

Drug Product Composition: Naratriptan Hydrochloride